Non-alcoholic Fatty Liver Disease: A Review of Anti-diabetic Pharmacologic Therapies

Non-alcoholic fatty liver disease (NAFLD), the most common cause of liver disease, affects approximately 75 to 100 million Americans. Patients with concurrent NAFLD and type 2 diabetes mellitus have a higher risk of progressing to advanced fibrosis and non-alcoholic steatohepatitis compared to non-d...

Descripción completa

Detalles Bibliográficos
Autores principales: Snyder, Heather S., Sakaan, Sami A., March, Katherine L., Siddique, Osama, Cholankeril, Rosann, Cummings, Carolyn D., Gadiparthi, Chiran, Satapathy, Sanjaya K., Ahmed, Aijaz, Cholankeril, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018310/
https://www.ncbi.nlm.nih.gov/pubmed/29951362
http://dx.doi.org/10.14218/JCTH.2017.00050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018310/
https://www.ncbi.nlm.nih.gov/pubmed/29951362
http://dx.doi.org/10.14218/JCTH.2017.00050

Ejemplares similares